Rehmann Capital Advisory Group - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 139 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rehmann Capital Advisory Group ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$3,992,000
+34.3%
1,1090.0%0.00%
Q2 2019$2,972,000
-9.4%
1,1090.0%0.00%
Q1 2019$3,282,000
+86.2%
1,1090.0%0.00%
Q4 2018$1,763,000
-56.8%
1,1090.0%0.00%
-100.0%
Q3 2018$4,081,000
+30.1%
1,1090.0%0.00%
Q2 2018$3,138,000
+78350.0%
1,1090.0%0.00%
-100.0%
Q1 2018$4,0001,1090.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
RA Capital Management 11,733,815$81,081,00011.64%
RTW INVESTMENTS, LP 2,589,818$17,896,0005.56%
DAFNA Capital Management LLC 480,300$3,319,0003.29%
DOHENY ASSET MANAGEMENT /CA 510,125$3,525,0001.83%
Sio Capital Management, LLC 364,368$2,518,0001.73%
TURNER INVESTMENTS LLC 1,086,000$7,504,0001.52%
Ghost Tree Capital, LLC 300,000$2,073,0000.93%
Rock Springs Capital Management LP 1,125,000$7,774,0000.63%
SENZAR ASSET MANAGEMENT, LLC 619,000$4,277,290,0000.62%
Point72 Asset Management, L.P. 9,772,018$67,525,0000.53%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders